191 related articles for article (PubMed ID: 19185466)
1. Differential relationship of frontal pole and whole brain volumetric measures with age in neuroleptic-naïve schizophrenia and healthy subjects.
John JP; Burgess PW; Yashavantha BS; Shakeel MK; Halahalli HN; Jain S
Schizophr Res; 2009 Apr; 109(1-3):148-58. PubMed ID: 19185466
[TBL] [Abstract][Full Text] [Related]
2. MRI assessment of gray and white matter distribution in Brodmann's areas of the cortex in patients with schizophrenia with good and poor outcomes.
Mitelman SA; Shihabuddin L; Brickman AM; Hazlett EA; Buchsbaum MS
Am J Psychiatry; 2003 Dec; 160(12):2154-68. PubMed ID: 14638586
[TBL] [Abstract][Full Text] [Related]
3. Dynamically spreading frontal and cingulate deficits mapped in adolescents with schizophrenia.
Vidal CN; Rapoport JL; Hayashi KM; Geaga JA; Sui Y; McLemore LE; Alaghband Y; Giedd JN; Gochman P; Blumenthal J; Gogtay N; Nicolson R; Toga AW; Thompson PM
Arch Gen Psychiatry; 2006 Jan; 63(1):25-34. PubMed ID: 16389194
[TBL] [Abstract][Full Text] [Related]
4. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study.
Lui S; Deng W; Huang X; Jiang L; Ma X; Chen H; Zhang T; Li X; Li D; Zou L; Tang H; Zhou XJ; Mechelli A; Collier DA; Sweeney JA; Li T; Gong Q
Am J Psychiatry; 2009 Feb; 166(2):196-205. PubMed ID: 18981063
[TBL] [Abstract][Full Text] [Related]
5. A proposal for MRI-based parcellation of the frontal pole.
John JP; Yashavantha BS; Gado M; Veena R; Jain S; Ravishankar S; Csernansky JG
Brain Struct Funct; 2007 Dec; 212(3-4):245-53. PubMed ID: 17929054
[TBL] [Abstract][Full Text] [Related]
6. Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities.
Davatzikos C; Shen D; Gur RC; Wu X; Liu D; Fan Y; Hughett P; Turetsky BI; Gur RE
Arch Gen Psychiatry; 2005 Nov; 62(11):1218-27. PubMed ID: 16275809
[TBL] [Abstract][Full Text] [Related]
7. Reduced gray matter volume of Brodmann's Area 45 is associated with severe psychotic symptoms in patients with schizophrenia.
Suga M; Yamasue H; Abe O; Yamasaki S; Yamada H; Inoue H; Takei K; Aoki S; Kasai K
Eur Arch Psychiatry Clin Neurosci; 2010 Sep; 260(6):465-73. PubMed ID: 20020306
[TBL] [Abstract][Full Text] [Related]
8. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
Semkovska M; Bédard MA; Stip E
Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
[TBL] [Abstract][Full Text] [Related]
9. Localized gray matter volume reductions in the pars triangularis of the inferior frontal gyrus in individuals at clinical high-risk for psychosis and first episode for schizophrenia.
Iwashiro N; Suga M; Takano Y; Inoue H; Natsubori T; Satomura Y; Koike S; Yahata N; Murakami M; Katsura M; Gonoi W; Sasaki H; Takao H; Abe O; Kasai K; Yamasue H
Schizophr Res; 2012 May; 137(1-3):124-31. PubMed ID: 22425035
[TBL] [Abstract][Full Text] [Related]
10. Association between a longer duration of illness, age and lower frontal lobe grey matter volume in schizophrenia.
Premkumar P; Fannon D; Kuipers E; Cooke MA; Simmons A; Kumari V
Behav Brain Res; 2008 Nov; 193(1):132-9. PubMed ID: 18586335
[TBL] [Abstract][Full Text] [Related]
11. Insular cortex abnormalities in schizophrenia: Relationship to symptoms and typical neuroleptic exposure.
Pressler M; Nopoulos P; Ho BC; Andreasen NC
Biol Psychiatry; 2005 Feb; 57(4):394-8. PubMed ID: 15705355
[TBL] [Abstract][Full Text] [Related]
12. Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study.
van Haren NE; Hulshoff Pol HE; Schnack HG; Cahn W; Mandl RC; Collins DL; Evans AC; Kahn RS
Neuropsychopharmacology; 2007 Oct; 32(10):2057-66. PubMed ID: 17327887
[TBL] [Abstract][Full Text] [Related]
13. Smaller frontal gray matter volume in postmortem schizophrenic brains.
Selemon LD; Kleinman JE; Herman MM; Goldman-Rakic PS
Am J Psychiatry; 2002 Dec; 159(12):1983-91. PubMed ID: 12450946
[TBL] [Abstract][Full Text] [Related]
14. The relationship of structural alterations to cognitive deficits in schizophrenia: a voxel-based morphometry study.
Antonova E; Kumari V; Morris R; Halari R; Anilkumar A; Mehrotra R; Sharma T
Biol Psychiatry; 2005 Sep; 58(6):457-67. PubMed ID: 16039619
[TBL] [Abstract][Full Text] [Related]
15. Prefrontal cortex and insight in schizophrenia: a volumetric MRI study.
Sapara A; Cooke M; Fannon D; Francis A; Buchanan RW; Anilkumar AP; Barkataki I; Aasen I; Kuipers E; Kumari V
Schizophr Res; 2007 Jan; 89(1-3):22-34. PubMed ID: 17097853
[TBL] [Abstract][Full Text] [Related]
16. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
[TBL] [Abstract][Full Text] [Related]
17. Association of IQ Changes and Progressive Brain Changes in Patients With Schizophrenia.
Kubota M; van Haren NE; Haijma SV; Schnack HG; Cahn W; Hulshoff Pol HE; Kahn RS
JAMA Psychiatry; 2015 Aug; 72(8):803-12. PubMed ID: 26083394
[TBL] [Abstract][Full Text] [Related]
18. Volumetric white matter abnormalities in first-episode schizophrenia: a longitudinal, tensor-based morphometry study.
Whitford TJ; Grieve SM; Farrow TF; Gomes L; Brennan J; Harris AW; Gordon E; Williams LM
Am J Psychiatry; 2007 Jul; 164(7):1082-9. PubMed ID: 17606660
[TBL] [Abstract][Full Text] [Related]
19. Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls.
Witthaus H; Kaufmann C; Bohner G; Ozgürdal S; Gudlowski Y; Gallinat J; Ruhrmann S; Brüne M; Heinz A; Klingebiel R; Juckel G
Psychiatry Res; 2009 Sep; 173(3):163-9. PubMed ID: 19616415
[TBL] [Abstract][Full Text] [Related]
20. Globally and locally reduced MRI gray matter volumes in neuroleptic-naive men with schizotypal personality disorder: association with negative symptoms.
Asami T; Whitford TJ; Bouix S; Dickey CC; Niznikiewicz M; Shenton ME; Voglmaier MM; McCarley RW
JAMA Psychiatry; 2013 Apr; 70(4):361-72. PubMed ID: 23389420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
